Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 27 Apr 2026 for Amicus Therapeutics, INC., €1.8M. Read the official filing
Filing timeline
BuySaleGlenn Sblendorio
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Glenn Sblendorio: trading record in brief
Filings by Glenn Sblendorio span 4 companies, the busiest being IVERIC bio, Inc., Amicus Therapeutics, Inc. and Intercept Pharmaceuticals, Inc. Between 30 December 2015 and 27 April 2026, the trades on record add up to 32 filings.
On the market, this insider has only sold: 3 sales, €2.0M in total. The amount is not disclosed for 1 filing. The rest of the record consists of 9 share grants and 16 option exercises.
The newest entry dates from 27 April 2026: a transaction of €1.8M, in Amicus Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Glenn Sblendorio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
142,564 shares@ US$14.500.044% mcap92.2% of flowCommon StockSEC:0001193125-26-182278:0
6,200 shares0Common StockSEC:0001933414-26-000044:0
20,414 shares0Common StockSEC:0000950170-25-083220:0
11,847 shares0Common StockSEC:0000950170-24-071004:0
15,000 shares@ US$2.8025.7% of flowCommon StockSEC:0000950170-24-029458:0
23,447 shares@ US$19.00100.0% of flowCommon StockSEC:0001104659-23-117109:0
239,275 sharesCommon StockSEC:0001104659-23-080686:0
11,084 shares@ US$13.2165.9% of flowCommon StockSEC:0001410939-23-000099:0
8,584 shares0Common StockSEC:0001209191-23-036418:0
8,111 shares0Common StockSEC:0001104659-23-064845:0
15,000 shares@ US$3.3230.9% of flowCommon StockSEC:0001209191-23-031103:0
31,500 shares0Common StockSEC:0001410939-23-000008:0
30,000 shares0Common StockSEC:0001410939-22-000152:0
36,658 shares0Common StockSEC:0001410939-22-000138:0
23,750 shares0Common StockSEC:0001410939-22-000126:0
50,000 shares@ US$23.0151.2% of flowCommon StockSEC:0001410939-22-000110:0
12,671 shares0Common StockSEC:0001209191-22-035852:0
7,737 shares0Common StockSEC:0001104659-22-065913:0
50,000 shares@ US$18.756187.7% of flowCommon StockSEC:0001410939-22-000048:0
1,213 shares@ US$2.940.3% of flowCommon StockSEC:0001410939-22-000040:0
18,775 shares@ US$2.942.2% of flowCommon StockSEC:0001410939-22-000031:0
3,479 shares@ US$2.940.4% of flowCommon StockSEC:0001410939-22-000023:0
15,000 shares@ US$4.793.4% of flowCommon StockSEC:0001209191-22-016793:0
100 shares@ US$2.940.0% of flowCommon StockSEC:0001104659-22-000502:0
22,163 shares@ US$1.451.3% of flowCommon StockSEC:0001104659-21-153685:0
25 of 32 declarations
